publication venue for
- Driving human–mouse avatars to understand the HSC niche. 13:1511-1512. 2014
- The locus of microRNA-10b. 12:2371-2375. 2013
- Gender, mutant p53 and PML: A growing "affaire" in tumor suppression and oncogenesis. 12:1824-1825. 2013
- Gender, mutant p53 and PML: A growing “affaire” in tumor suppression and oncogenesis. 12:1824-1825. 2013
- MicroRNA-181a/b: Novel biomarkers to stratify breast cancer patients for PARPi treatment. 12:1823-1823. 2013
- MicroRNA-181a/b: Novel biomarkers to stratify breast cancer patients for PARPi treatment. 12:1823-1824. 2013
- Interactions of pro-apoptotic BH3 proteins with anti-apoptotic Bcl-2 family proteins measured in live MCF-7 cells using FLIM FRET. 11:3536-3542. 2012
- Human pluripotency: A difficult state to make smart choices. 11:2411-2412. 2012
- Butein impairs the protumorigenic activity of malignant pleural mesothelioma cells. 11:132-140. 2012
- Mutant p53 oncogenic functions are sustained by Plk2 kinase through an autoregulatory feedback loop. 10:4330-4340. 2011
- Cell Fate Potential of Human Pluripotent Stem Cells Is Encoded by Histone Modifications. 9:24-36. 2011
- p53: The pivot between cell cycle arrest and senescence. 9:4266-4265. 2010
- Mammosphere-forming cells from breast cancer cell lines as a tool for the identification of CSC-like- and early progenitor-targeting drugs. 9:2950-2959. 2010
- Novel insights into the cytoplasmic functions of p53. 9:2491-2501. 2010
- Id2gene is a transcriptional target of the protein complex mutant p53/E2F1. 9:2464-2466. 2010
- Stability strengths oncogenic activity. 9:1456-1465. 2010
- Characterization of a new cancer-associated mutant of p53 with a missense mutation (K351N) in the tetramerization domain. 8:3396-3405. 2009
- Metformin, diet and breast cancer: An avenue for chemoprevention. 8:2661-2661. 2009
- p63 regulation by microRNAs. 8:1466-1470. 2009
- Tetraploidy triggers mithocondria. 8:1305-1307. 2009
- YAP: At the crossroad between transformation and tumor suppression. 8:49-57. 2009
- Mitosis poisons p53. 7:3288-3290. 2008
- The disruption of the protein complex mutantp53/p73 increases selectively the response of tumor cells to anticancer drugs. 7:3440-3447. 2008
- Conditional RNA interference in vivo to study mutant p53 oncogenic gain of function on tumor malignancy. 7:1870-1879. 2008
- Inflammation in Obesity is a Common Link Between Defects in Fatty Acid Metabolism and Insulin Resistance. 6:888-894. 2007
- p73 and p63: Why Do We Still Need Them?. 3:884-892. 2004
- p73-Mediated Chemosensitivity: A Preferential Target of Oncogenic Mutant p53. 2:345-346. 2003